Reversible model of magnesium depletion induced by systemic kainic acid injection in magnesium-deficient rats: I - Comparative study of various magnesium salts

Magnesium Research

Volumn 9, Issue 4, 1996, Pages 281-291

  Bac, Pierre ^a   Herrenknecht, Christine ^a   Pagès, Nicole ^a   Dupont, Charlotte ^a   Durlach, Jean ^b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Kainic acid; Magnesium acetyltaurinate; Magnesium aspartate; Magnesium chloride; Magnesium deficiency; Magnesium depletion; Magnesium gluconate; Magnesium lactate; Magnesium pidolate; Sodium acetyltaurinate

Indexed keywords

CANIS FAMILIARIS;

ACETYLTAURINE; DRUG DERIVATIVE; KAINIC ACID; MAGNESIUM; TAURINE;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DISEASE MODEL; INTRAPERITONEAL DRUG ADMINISTRATION; MAGNESIUM DEFICIENCY; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; RAT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; DISEASE MODELS, ANIMAL; FOOD, FORTIFIED; INJECTIONS, INTRAPERITONEAL; KAINIC ACID; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; RATS; RATS, SPRAGUE-DAWLEY; TAURINE;

EID: 0030322672     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Durlach, J. (1988): Magnesium in clinical practice. pp 360. London, Paris: John Libbey Eurotext.
2. Kubena, K.S. & Durlach, J. (1990): Historical review of the effects of marginal intake of magnesium in chronic experimental magnesium deficiency. Magnes. Res. 3, 219-226.
3. Durlach, J., Durlach, V., Bac, P., Bara, M. & Guiet-Bara, A. (1994): Magnesium and therapeutics. Magnes. Res. 7, 313-328.
4. Durlach, J. Present and future of magnesium research (1993): J. of Japan. Soc. for Magnes. Res. 12, 113-135.
5. Henrotte, J.G., Aymard, N., Leyris, A., Monier, C., Frances, H. & Boulu R. (1993): Brain weight and noradrenaline content in mice selected for low (MGL) and high (MGH) blood magnesium. Magnes. Res. 6, 21-24.
6. Henrotte, J.G., Franck, G., Santarromana, M., Leloup, P., Motta, R., Biozzi, G. & Mouton, D. (1988): Selection of two lines of mice for high and low blood cell magnesium concentrations called MGH (high) and MGL (low). Mouse New Lett. 81, 84-85.
7. Mazur, A., Gueux, E., Remesy, Y., Demigne, C. & Rayssiguier, Y. (1989): Plasma and red blood cell magnesium in Zucker rats: influence of a high fibre diet. Magnes. Res. 2, 189-192.
8. Vink, R. & McIntosh, T.K. (1990): Pharmacological and physiological effect of magnesium on experimental traumatic brain injury. Magnes. Res. 3, 163-169.
9. Cernak, I., Radosevic, P.. Malicevic, Z. & Savic J. (1995): Experimental magnesium depletion in adult rabbits caused by blast overpressure. Magnes. Res. 8, 249-259.
10. Bac, P., Herrenknecht, C., Binet, P. & Durlach, J. (1993): Audiogenic seizures in magnesium-deficient mice: effects of magnesium pyrrolidone-2-carboxylate, magnesium acetyltaurinate, magnesium chloride and vitamin B-6. Magnes. Res. 6, 11-19.
11. Bac, P., Pages, N., Herrenknecht, C. & Teste J.G. (1995): Inhibition of mouse-killing behaviour in magnesium-deficient rats: effects of pharmacological doses of magnesium pidolate, magnesium aspartate, magnesium lactate, magnesium gluconate and magnesium chloride. Magnes. Res. 8, 37-45.
12. Smalheiser, N.R. & Swanson, D.R. (1994): Assessing a gap in the biomedical literature. Magnesium deficiency and neurologic diseases. Neuro. Res. Comm. 15, 1-9.
13. Durlach, J. (1990): Magnesium depletion and pathogenesis of Alzheimer's disease. Magnes. Res. 3, 217-218.
14. Rayssiguier, Y., Durlach, J., Gueux, E., Rock, E. & Mazur, A. (1993): Magnesium and ageing. I. Experimental data: importance of oxidative damage. Magnes. Res. 6, 369-378.
15. Durlach, J., Durlach, V., Bac, P., Rayssiguier, Y., Bara, M. & Guiet-Bara, A. (1993): Magnesium and ageing. II Clinical data: aetiological mechanisms and physiopathological consequences of magnesium deficit in the elderly. Magnes. Res. 6, 379-394.
16. Choi, D.W. (1988): Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-624.
17. Bruno, V., Scapagnini, U. & Canonico P.L. (1993): Excitatory amino acids and neurotoxicity. Funct. Neurol. 8, 279292.
18. Vornov, J.J., Tasker, R.C. & Park, J. (1995): Neurotoxicity of acute glutamate transport blockade depends on coactivation of both NMDA and AMPA/kainate receptors in organotypic hippocampal cultures. Exp. Neurol. 133, 7-17.
19. Sperk, G. (1994): Kainic acid seizures in the rat. Prog. Neurobiol. 42, 1-32.
20. Hruska, R.E. & Silbergeld, E.K. (1979): Abnormal locomotion in rats after bilateral intrastriatal injection of kainic acid. Life Science 25, 181-194.
21. Dawson, R. & Wallace, D.R. (1992): Kainic acid-induced seizures in aged rats: neurochemical correlate. Brain Research 29, 459-468.
22. De Vera, N., Serratosa, J. & Martinez, E. (1991): Kainic acid administration: relationship to convulsant activity and brain damage. J. Neurochem. 157, 1-8.
23. Sapolsky, M. (1986): Glucocorticoid toxicity in the hippocampus: temporal aspects of synergy with kainic acid. Neuroendocrinology 43, 440-444.
24. Fowler, K.R. & Olton, D. (1984): Recovery of function following injections of kainic acid: behavioral, electrophysiological and neuroanatomical correlates. Brain Res. 321, 21-32.
25. Letty, S., Lernernatoli, M. & Rondouin, G. (1995): Differential impairments of spatial memory and social behavior in two models of limbic epilepsy. Epilepsia 36, 973-982.
26. Dawson, R. Beal, M.F., Dimonte, D.A. & Isom, G.E. (1995): Excitotoxins, aging, and environmental neurotoxins- implications for understanding human neurodegenerative diseases. Toxicol. Appl. Pharmacol. 134, 1-17.
27. Honore, T. (1989): Excitatory amino acid receptor subtypes and specific antagonists. Med. Res. Rev. 9, 1-23.
28. Wolf G., Fischer S., Hass P., Abicht K. & Keilhoff G. (1991): Magnesium sulphate subcutaneously injected protects against kainate-Induced convulsions and neurodegeneration: in vivo study on the rat hippocampus. Neuroscience 43, 31-34.
29. 2+ antagonizes α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced brain damage and convulsions. Eur. J. Pharmacol. 232, 121-124.
30. Wolf, G., Keilhoff, G., Fischer, S., & Hass, P. (1990): Subcutaneously applied magnesium protects reliably against quinolinate- induced N-methyl-D-aspartate (NMDA)-mediated neurodegeneration and convulsions in rats: are there therapeutical implications? Neurose. Lett. 117, 207-211.
31. Cotton, D.B., Janusz, C.A. & Berman, R.F. (1992): Anticonvulsant effects of magnesium sulphate on hippocampal seizures: therapeutic implications in preeclampsia-eclampsia. Am. J. Obst. Gyn. 166, 1127-1136.
32. Boissier, J.R. & Simon, P. (1964): Dissociation de deux composantes dans le comportement d'investigation de la souris. Arch. Int. Pharmacodyn. 147, 372-387.
33. Durlach, J., Poenaru, S., Rouhani, S., Bara M. & Guiet-Bara A. (1987): The control of central neural hyperexcitability in magnesium deficiency. In: Nutrients and brain function, ed. W.B. Essman, PP 49-71. Basel: Karger.
34. Berg, M., Bruhn T., Frandsen, A., Schousboe A. & Diemer, N.H. (1995): Kainic acid-induced seizures and brain damage in the rat - role of calcium homeostasis. J. Neurosci. Res. 40, 641-646.
35. Bruce, A.J. & Baudry M. (1995): Oxygen free radicals in rat limbic structures after kainate-induced seizures. Free Rad. Biol. Med. 18, 993-1002.
36. Durlach, J. & Bac, P. (1997): Mechanisms of action on nervous system in magnesium deficiency and dementia. In: Mineral and metal neurotoxicology, eds. M. Yasui, M.J. Strong, K. Ota % M.A. Verity, CRC Press Boca Raton, New York, London, Tokyo, pp 201-210.
37. Poenaru, S., Durlach, J., Aymard, P., Rouhani, S., Manicom, R., Crosnier J.M., Rayssiguier, Y., Emmanouilidis, E., Nkanga, N., Soulairac, A. & Poenaru, L. (1991): Study of the relationship between levels of magnesium, lysosomal enzymes and monoamines in different cerebral structures in the magnesium-deficient rat. Magnes. Res. 4, 246-247.
38. Lenicque, P.M., Wepierre, J. & Cohen, Y. (1981): The role of monoamines in the behavioural effects of kainic acid in rats. J. Neural Trans. 51, 205-212.
39. Molla-Hosseini, C., Lenicque, P.M., Wepierre, J. & Cohen, Y. (1985): Modulation of action of kainic acid on the behavior of rats by p-chlorophenylalanine and by gaba-mimetic drugs. Biochemical correlation between behavior and treatments. J. Pharmacol (Paris), 16, 299-312.
40. Halonen, T., Miettinen, R., Toppinen, A., Tuunanen, J., Kotti, T. & Riekkinen, P.J. (1995): Vigabatrin protects against kainic acid-induced neuronal damage in the rat hippocampus. Neurosci. Let 195, 13-16.
41. Binet, P., Miocque, M., Pechery, C., Roux, M. & Rinjard, P. (1978): Effet correcteur comparé du pyrrolidone-2-carboxylate de magnésium et du chlorure de magnésium sur les troubles cutanés et hématologiques de la carence magnésique expérimentale du rat. Thérapie 33, 491-500.
42. Huxtable, R.J. (1992): Physiological actions of taurine. Physiological Reviews 72, 101-163.
43. Huxtable, R.J. (1989): Taurine in the central nervous system and the mammalian actions of taurine. Progress in Neurobiology, 32, 471-533.
44. Schousboe, A. (1992): Role of taurine in neural cell volume regulation. Can. J. Physiol. Pharmacol. 70, s356-s361.
45. Oja, S.S. & Saransaari, P. (1994): Relation of taurine release and influx to cell volume in cerebral cortical slices. In: Taurine in health and disease, ed. R.J. Huxtable & D. Michalk, pp 269-277 Plenum press New York and London.
46. Saransaari, P. & Oja, S.S. (1994): Taurine release from mouse hippocampal slices: effects of glutamergic subtances and hypoxia. In: Taurine in health and disease, ed. R.J. Huxtable & D. Michalk, pp 279-287. Plenum press New York and London.
47. Schurr, A. & Rigor, B.M. (1987): The mechanism of neuronal resistance and adaptation to hypoxia. FEBS Let 224, 4-8.
48. Fariello, R.G., Golden, G. T. & Pisa, M. (1982): Homotaurine (3 aminopropanesulfonic acid; 3APS) protects from the convulsant and cytotoxic effects of systemically administered kainic acid. Neurology 32, 241-245.